Medical Care

Global LFA-based Cardiac Market Research Report 2025

The global market for LFA-based Cardiac was valued at US$ 4181 million in the year 2024 and is projected to reach a revised size of US$ 6210 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Lateral flow cardiac markers are a rapid detection tool based on lateral flow immunochromatography technology, which is used to qualitatively or quantitatively detect specific cardiac biomarkers in the blood (such as troponin I/T, myoglobin, BNP, etc.). The principle is to form a visual detection line on the test strip through antigen-antibody reaction, so as to quickly judge abnormal cardiac function or myocardial damage. This technology has the advantages of convenience, rapidity (results in 15-30 minutes), low cost, and no need for complex equipment. It is widely used in emergency, primary care, home self-testing and other scenarios.
Market drivers:
Disease demand growth:
Cardiovascular disease is the world's leading cause of death, with a large and growing patient base. China has more than 330 million cardiovascular disease patients, and there is an urgent need for early screening and immediate diagnosis.
Acute myocardial infarction, heart failure and other acute diseases require rapid testing (such as the demand for troponin immediate testing in chest pain centers), and lateral flow technology can shorten the diagnosis time and improve prognosis.
Policy promotion:
Tiered diagnosis and treatment: Policies guide the sinking of high-quality medical resources, and primary medical institutions (such as community hospitals and township health centers) need to be equipped with POCT (point-of-care testing) equipment. Lateral flow cardiac markers are the first choice because of their simple operation and low cost.
Medical insurance coverage: Some cardiac marker tests are included in medical insurance, reducing the burden on patients and improving the accessibility of testing.
Technology iteration:
Sensitivity improvement: The application of nanomaterials (such as gold nanoparticles) improves detection sensitivity and can detect low-concentration markers (such as high-sensitivity troponin).
Multi-indicator joint detection: The same test strip realizes the joint detection of multiple markers (such as troponin + BNP + D-dimer), improving diagnostic efficiency.
Intelligence: Combined with mobile phone APP or portable reader, the results can be automatically transmitted and interpreted to reduce human errors.
Application scenario expansion:
Pre-hospital emergency: rapid screening at ambulance and emergency scene, auxiliary decision-making (such as whether to transfer directly to the catheterization room).
Home monitoring: patients with chronic heart failure can self-test BNP at home and adjust drug dosage in time.
Physical examination screening: early cardiac function assessment for high-risk groups (such as patients with hypertension and diabetes).
Market trend:
Domestic substitution: domestic companies (such as Wondfo Biotech and Mindray Biotech) have made technological breakthroughs, breaking the import monopoly and reducing costs.
Standardized development: industry standards are gradually improved, promoting the transformation of product homogeneity to differentiated competition (such as specific marker detection and personalized services).
The lateral flow cardiac marker market is driven by disease demand, policy promotion, and technological upgrading. In the future, it will continue to develop in the direction of rapidity, multi-indicators, and intelligence, and become an important tool for the diagnosis and treatment of cardiovascular diseases.
This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac.
The LFA-based Cardiac market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global LFA-based Cardiac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LFA-based Cardiac companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
EasyDiagnosis Biomedicine
Segment by Type
Troponin I
Troponin T
CK-MB
Myoglobin
Others
Segment by Application
Laboratory Testing
Point-of-care Testing
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LFA-based Cardiac company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global LFA-based Cardiac Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Troponin I
1.2.3 Troponin T
1.2.4 CK-MB
1.2.5 Myoglobin
1.2.6 Others
1.3 Market by Application
1.3.1 Global LFA-based Cardiac Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global LFA-based Cardiac Market Perspective (2020-2031)
2.2 Global LFA-based Cardiac Growth Trends by Region
2.2.1 Global LFA-based Cardiac Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 LFA-based Cardiac Historic Market Size by Region (2020-2025)
2.2.3 LFA-based Cardiac Forecasted Market Size by Region (2026-2031)
2.3 LFA-based Cardiac Market Dynamics
2.3.1 LFA-based Cardiac Industry Trends
2.3.2 LFA-based Cardiac Market Drivers
2.3.3 LFA-based Cardiac Market Challenges
2.3.4 LFA-based Cardiac Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LFA-based Cardiac Players by Revenue
3.1.1 Global Top LFA-based Cardiac Players by Revenue (2020-2025)
3.1.2 Global LFA-based Cardiac Revenue Market Share by Players (2020-2025)
3.2 Global Top LFA-based Cardiac Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by LFA-based Cardiac Revenue
3.4 Global LFA-based Cardiac Market Concentration Ratio
3.4.1 Global LFA-based Cardiac Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Revenue in 2024
3.5 Global Key Players of LFA-based Cardiac Head office and Area Served
3.6 Global Key Players of LFA-based Cardiac, Product and Application
3.7 Global Key Players of LFA-based Cardiac, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 LFA-based Cardiac Breakdown Data by Type
4.1 Global LFA-based Cardiac Historic Market Size by Type (2020-2025)
4.2 Global LFA-based Cardiac Forecasted Market Size by Type (2026-2031)
5 LFA-based Cardiac Breakdown Data by Application
5.1 Global LFA-based Cardiac Historic Market Size by Application (2020-2025)
5.2 Global LFA-based Cardiac Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America LFA-based Cardiac Market Size (2020-2031)
6.2 North America LFA-based Cardiac Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America LFA-based Cardiac Market Size by Country (2020-2025)
6.4 North America LFA-based Cardiac Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe LFA-based Cardiac Market Size (2020-2031)
7.2 Europe LFA-based Cardiac Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe LFA-based Cardiac Market Size by Country (2020-2025)
7.4 Europe LFA-based Cardiac Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific LFA-based Cardiac Market Size (2020-2031)
8.2 Asia-Pacific LFA-based Cardiac Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific LFA-based Cardiac Market Size by Region (2020-2025)
8.4 Asia-Pacific LFA-based Cardiac Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America LFA-based Cardiac Market Size (2020-2031)
9.2 Latin America LFA-based Cardiac Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America LFA-based Cardiac Market Size by Country (2020-2025)
9.4 Latin America LFA-based Cardiac Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LFA-based Cardiac Market Size (2020-2031)
10.2 Middle East & Africa LFA-based Cardiac Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa LFA-based Cardiac Market Size by Country (2020-2025)
10.4 Middle East & Africa LFA-based Cardiac Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche LFA-based Cardiac Introduction
11.1.4 Roche Revenue in LFA-based Cardiac Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott LFA-based Cardiac Introduction
11.2.4 Abbott Revenue in LFA-based Cardiac Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens LFA-based Cardiac Introduction
11.3.4 Siemens Revenue in LFA-based Cardiac Business (2020-2025)
11.3.5 Siemens Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher LFA-based Cardiac Introduction
11.4.4 Danaher Revenue in LFA-based Cardiac Business (2020-2025)
11.4.5 Danaher Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories LFA-based Cardiac Introduction
11.5.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2020-2025)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 BioMérieux
11.6.1 BioMérieux Company Details
11.6.2 BioMérieux Business Overview
11.6.3 BioMérieux LFA-based Cardiac Introduction
11.6.4 BioMérieux Revenue in LFA-based Cardiac Business (2020-2025)
11.6.5 BioMérieux Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher LFA-based Cardiac Introduction
11.7.4 Thermo Fisher Revenue in LFA-based Cardiac Business (2020-2025)
11.7.5 Thermo Fisher Recent Development
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Details
11.8.2 Ortho Clinical Diagnostics Business Overview
11.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Introduction
11.8.4 Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2020-2025)
11.8.5 Ortho Clinical Diagnostics Recent Development
11.9 LSI Medience Corporation
11.9.1 LSI Medience Corporation Company Details
11.9.2 LSI Medience Corporation Business Overview
11.9.3 LSI Medience Corporation LFA-based Cardiac Introduction
11.9.4 LSI Medience Corporation Revenue in LFA-based Cardiac Business (2020-2025)
11.9.5 LSI Medience Corporation Recent Development
11.10 Randox laboratories
11.10.1 Randox laboratories Company Details
11.10.2 Randox laboratories Business Overview
11.10.3 Randox laboratories LFA-based Cardiac Introduction
11.10.4 Randox laboratories Revenue in LFA-based Cardiac Business (2020-2025)
11.10.5 Randox laboratories Recent Development
11.11 Wondfo Biotech
11.11.1 Wondfo Biotech Company Details
11.11.2 Wondfo Biotech Business Overview
11.11.3 Wondfo Biotech LFA-based Cardiac Introduction
11.11.4 Wondfo Biotech Revenue in LFA-based Cardiac Business (2020-2025)
11.11.5 Wondfo Biotech Recent Development
11.12 EasyDiagnosis Biomedicine
11.12.1 EasyDiagnosis Biomedicine Company Details
11.12.2 EasyDiagnosis Biomedicine Business Overview
11.12.3 EasyDiagnosis Biomedicine LFA-based Cardiac Introduction
11.12.4 EasyDiagnosis Biomedicine Revenue in LFA-based Cardiac Business (2020-2025)
11.12.5 EasyDiagnosis Biomedicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global LFA-based Cardiac Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Troponin I
Table 3. Key Players of Troponin T
Table 4. Key Players of CK-MB
Table 5. Key Players of Myoglobin
Table 6. Key Players of Others
Table 7. Global LFA-based Cardiac Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global LFA-based Cardiac Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global LFA-based Cardiac Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global LFA-based Cardiac Market Share by Region (2020-2025)
Table 11. Global LFA-based Cardiac Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global LFA-based Cardiac Market Share by Region (2026-2031)
Table 13. LFA-based Cardiac Market Trends
Table 14. LFA-based Cardiac Market Drivers
Table 15. LFA-based Cardiac Market Challenges
Table 16. LFA-based Cardiac Market Restraints
Table 17. Global LFA-based Cardiac Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global LFA-based Cardiac Market Share by Players (2020-2025)
Table 19. Global Top LFA-based Cardiac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac as of 2024)
Table 20. Ranking of Global Top LFA-based Cardiac Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by LFA-based Cardiac Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of LFA-based Cardiac, Headquarters and Area Served
Table 23. Global Key Players of LFA-based Cardiac, Product and Application
Table 24. Global Key Players of LFA-based Cardiac, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global LFA-based Cardiac Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Table 28. Global LFA-based Cardiac Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global LFA-based Cardiac Revenue Market Share by Type (2026-2031)
Table 30. Global LFA-based Cardiac Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Table 32. Global LFA-based Cardiac Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global LFA-based Cardiac Revenue Market Share by Application (2026-2031)
Table 34. North America LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America LFA-based Cardiac Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America LFA-based Cardiac Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe LFA-based Cardiac Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe LFA-based Cardiac Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific LFA-based Cardiac Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific LFA-based Cardiac Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific LFA-based Cardiac Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America LFA-based Cardiac Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America LFA-based Cardiac Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa LFA-based Cardiac Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa LFA-based Cardiac Market Size by Country (2026-2031) & (US$ Million)
Table 49. Roche Company Details
Table 50. Roche Business Overview
Table 51. Roche LFA-based Cardiac Product
Table 52. Roche Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Abbott Company Details
Table 55. Abbott Business Overview
Table 56. Abbott LFA-based Cardiac Product
Table 57. Abbott Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 58. Abbott Recent Development
Table 59. Siemens Company Details
Table 60. Siemens Business Overview
Table 61. Siemens LFA-based Cardiac Product
Table 62. Siemens Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 63. Siemens Recent Development
Table 64. Danaher Company Details
Table 65. Danaher Business Overview
Table 66. Danaher LFA-based Cardiac Product
Table 67. Danaher Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 68. Danaher Recent Development
Table 69. Bio-Rad Laboratories Company Details
Table 70. Bio-Rad Laboratories Business Overview
Table 71. Bio-Rad Laboratories LFA-based Cardiac Product
Table 72. Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 73. Bio-Rad Laboratories Recent Development
Table 74. BioMérieux Company Details
Table 75. BioMérieux Business Overview
Table 76. BioMérieux LFA-based Cardiac Product
Table 77. BioMérieux Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 78. BioMérieux Recent Development
Table 79. Thermo Fisher Company Details
Table 80. Thermo Fisher Business Overview
Table 81. Thermo Fisher LFA-based Cardiac Product
Table 82. Thermo Fisher Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 83. Thermo Fisher Recent Development
Table 84. Ortho Clinical Diagnostics Company Details
Table 85. Ortho Clinical Diagnostics Business Overview
Table 86. Ortho Clinical Diagnostics LFA-based Cardiac Product
Table 87. Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 88. Ortho Clinical Diagnostics Recent Development
Table 89. LSI Medience Corporation Company Details
Table 90. LSI Medience Corporation Business Overview
Table 91. LSI Medience Corporation LFA-based Cardiac Product
Table 92. LSI Medience Corporation Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 93. LSI Medience Corporation Recent Development
Table 94. Randox laboratories Company Details
Table 95. Randox laboratories Business Overview
Table 96. Randox laboratories LFA-based Cardiac Product
Table 97. Randox laboratories Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 98. Randox laboratories Recent Development
Table 99. Wondfo Biotech Company Details
Table 100. Wondfo Biotech Business Overview
Table 101. Wondfo Biotech LFA-based Cardiac Product
Table 102. Wondfo Biotech Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 103. Wondfo Biotech Recent Development
Table 104. EasyDiagnosis Biomedicine Company Details
Table 105. EasyDiagnosis Biomedicine Business Overview
Table 106. EasyDiagnosis Biomedicine LFA-based Cardiac Product
Table 107. EasyDiagnosis Biomedicine Revenue in LFA-based Cardiac Business (2020-2025) & (US$ Million)
Table 108. EasyDiagnosis Biomedicine Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 112. Authors List of This Report


List of Figures
Figure 1. LFA-based Cardiac Picture
Figure 2. Global LFA-based Cardiac Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global LFA-based Cardiac Market Share by Type: 2024 VS 2031
Figure 4. Troponin I Features
Figure 5. Troponin T Features
Figure 6. CK-MB Features
Figure 7. Myoglobin Features
Figure 8. Others Features
Figure 9. Global LFA-based Cardiac Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global LFA-based Cardiac Market Share by Application: 2024 VS 2031
Figure 11. Laboratory Testing Case Studies
Figure 12. Point-of-care Testing Case Studies
Figure 13. LFA-based Cardiac Report Years Considered
Figure 14. Global LFA-based Cardiac Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global LFA-based Cardiac Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global LFA-based Cardiac Market Share by Region: 2024 VS 2031
Figure 17. Global LFA-based Cardiac Market Share by Players in 2024
Figure 18. Global LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by LFA-based Cardiac Revenue in 2024
Figure 20. North America LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America LFA-based Cardiac Market Share by Country (2020-2031)
Figure 22. United States LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe LFA-based Cardiac Market Share by Country (2020-2031)
Figure 26. Germany LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific LFA-based Cardiac Market Share by Region (2020-2031)
Figure 34. China LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America LFA-based Cardiac Market Share by Country (2020-2031)
Figure 42. Mexico LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa LFA-based Cardiac Market Share by Country (2020-2031)
Figure 46. Turkey LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE LFA-based Cardiac Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Roche Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 50. Abbott Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 51. Siemens Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 52. Danaher Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 54. BioMérieux Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 55. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 56. Ortho Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 57. LSI Medience Corporation Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 58. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 59. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 60. EasyDiagnosis Biomedicine Revenue Growth Rate in LFA-based Cardiac Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies